 ENGLEWOOD, Colo., June 14, 2021 PRNewswire -- Ampio Pharmaceuticals NYSE American: AMPE, a clinical stage biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, today announced details on the Companys poster presentation, Pivoting From One to Multiple Production Platforms to Treat COVID, being given at the 2021 International Society for Pharmaceutical Engineers ISPE Annual Meeting and Expo in Boston, Massachusetts from November 1 st to 3rd, 2021. 